Enhabit Sees Adjusted Q2 Core Profit Between $24.5M to $25M
Digi Intl Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/15/2024 8.04% Piper Sandler $29 → $27 Maintains Neutral 05/03/2024 52.06% Roth MKM $40 → $38
Armada Hoffler Properties Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/15/2024 -4.43% Jefferies $13 → $11 Downgrades Buy → Hold 06/30/2022 21.63% Jefferies $18 → $14
Beyond The Numbers: 4 Analysts Discuss Regal Rexnord Stock
Throughout the last three months, 4 analysts have evaluated Regal Rexnord (NYSE:RRX), offering a diverse set of opinions from bullish to bearish.The following table encapsulates their recent ratings,
CommVault Systems Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/15/2024 0.01% Piper Sandler $107 → $123 Maintains Neutral 07/02/2024 13.83% Keybanc $122 → $140
Microsoft, Palantir, Others Expected to Be 'Standouts' During Earnings: Wedbush
Cactus Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/15/2024 -3% Piper Sandler $55 → $54 Maintains Neutral 07/10/2024 -6.59% Citigroup $48 → $52 Maintains
Top 5 Financials Stocks That May Collapse This Month
As of July 15, 2024, five stocks in the financials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.The RSI is a momentum indicator,
Patterson-UTI Energy Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/15/2024 17.88% Piper Sandler $14 → $12 Maintains Overweight 07/11/2024 27.7% Susquehanna $14 → $13
Oil States International Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/15/2024 27.91% Piper Sandler $7.5 → $5.5 Maintains Neutral 05/06/2024 74.42% Piper Sandler $8 → $7.5
Google-Wiz Deal Would Be 'Shot Across the Bow' at Microsoft, Amazon, Spur M&A: Wedbush
Liberty Energy Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/15/2024 18.2% Piper Sandler $28 → $25 Maintains Overweight 05/29/2024 51.3% Citigroup $24 → $32
Helmerich & Payne Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/15/2024 -2.09% Piper Sandler $39 → $36 Maintains Neutral 05/06/2024 6.06% Piper Sandler $44 → $39
This Analyst With 87% Accuracy Rate Sees More Than 12% Upside In AMD - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
U.S. stocks closed higher on Friday, with the Dow Jones index topping the key 40,000 mark during the session. The 30-stock blue-chip index gained around 1.6% last week.Wall Street analysts make new
Core Laboratories Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/15/2024 -21.59% Piper Sandler $18 → $17 Maintains Neutral 04/26/2024 -16.97% Stifel $17 → $18
ChampionX Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/15/2024 0.98% Piper Sandler $40 → $33 Maintains Neutral 04/08/2024 22.4% Piper Sandler $32 → $40
Atlas Energy Solutions Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/15/2024 28.63% Piper Sandler $29 → $27 Maintains Overweight 05/28/2024 33.4% Goldman Sachs $25 → $28
ANI's Generic L-Glutamine Oral Powder Hits Market, Targets $20.1M Annual Sales
ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ:ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (
ProFrac Holding Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/15/2024 13.78% Piper Sandler $11 → $9 Maintains Overweight 04/15/2024 20.1% B of A Securities $8.5 → $9
Select Medical's Concentra Launches IPO for 22.5M Shares on NYSE
Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced that Concentra Group Holdings Parent, Inc. ("Concentra"), a wholly owned subsidiary of Select Medical, has launched